• Users Online: 248
  • Print this page
  • Email this page
Year : 2021  |  Volume : 18  |  Issue : 3  |  Page : 155-159

Review on therapeutic trials for coronavirus disease-19

1 Department of Microbiology, Hammurabi College of Medicine, University of Babylon, Hilla, Iraq
2 Department of Clinical and Laboratory Sciences, Faculty of Pharmacy, Kufa University, Najaf, Iraq
3 Department of Medical Lab Technology, Shatrah Technical College, Southern Technical University, Thi Qar, Iraq

Correspondence Address:
Ayam M Salih
Department of Microbiology, Hammurabi College of Medicine, University of Babylon, Hilla.
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/MJBL.MJBL_103_20

Get Permissions

Our world was gripped by the coronavirus disease-19 (COVID-19) pandemic during the first months of the year 2020. It has been characterized as a new coronavirus (i.e., severe acute respiratory syndrome-CoV-2, which is an acute severe respiratory syndrome coronavirus, and later, it has been referred to as the coronavirus disease-19 or COVID-19. Whereas this disease has been originated in Wuhan city in the Chinese province of Hubei, it was capable of rapidly spreading all over the world, which has resulted in a human disaster as well as massive economic damages. By the middle of June 2020, there were more than 8 million COVID-19 cases all over the world, with more than 436,000 death cases. The aim of this review study was to investigate the most effective therapeutic trials for COVID-19.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded64    
    Comments [Add]    

Recommend this journal